| Literature DB >> 31795088 |
Caio Fernando Ramalho de Oliveira1, Taylla Michelle de Oliveira Flores2,3, Marlon Henrique Cardoso2,4, Karen Garcia Nogueira Oshiro2,5, Raphael Russi6, Anderson Felipe Jácome de França6, Elizeu Antunes Dos Santos6, Octávio Luiz Franco2,4,5, Adeliana Silva de Oliveira6, Ludovico Migliolo2,3,6.
Abstract
The Indianmeal moth, Plodia interpunctella, is one of the most damaging pests of stored products. We investigated the insecticidal properties of ApKTI, a Kunitz trypsin inhibitor from Adenanthera pavonina seeds, against P. interpunctella larvae through bioassays with artificial diet. ApKTI-fed larvae showed reduction of up to 88% on larval weight and 75% in survival. Trypsin enzymes extracted from P. interpunctella larvae were inhibited by ApKTI, which also demonstrated capacity to bind to chitin. Kinetic studies revealed a non-competitive inhibition mechanism of ApKTI for trypsin, which were further corroborated by molecular docking studies. Furthermore, we have demonstrated that ApKTI exhibits a hydrophobic pocket near the reactive site loop probably involved in chitin interactions. Taken together, these data suggested that the insecticidal activity of ApKTI for P. interpunctella larvae involves a dual and promiscuous mechanisms biding to two completely different targets. Both processes might impair the P. interpunctella larval digestive process, leading to larvae death before reaching the pupal stage. Further studies are encouraged using ApKTI as a biotechnological tool to control insect pests in field conditions.Entities:
Keywords: non-competitive inhibitor; peritrophic membrane; trypsin inhibitor
Mesh:
Substances:
Year: 2019 PMID: 31795088 PMCID: PMC6930628 DOI: 10.3390/molecules24234344
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Bioassays with P. interpunctella larvae. Artificial diet was enriched with ApKTI from 0.3% to 1.5% (w/w). At the final of bioassays (15 days) the weight (A) and survival (B) in each treatment were determined. In control treatment the artificial diet was supplemented with bovine serum albumin (BSA) at the same concentration of ApKTI. A linear regression was obtained from ApKTI-fed larvae demonstrating the dose-response effect. (C) Representative image of larvae of each treatment, in sequential order from the left: control-fed larvae, larvae fed with 0.3%, 0.5%, 1.0%, and 1.5% ApKTI.
Figure 2Purification of ApKTI. (A) The fraction F40-60% from ammonium sulfate precipitation was fractioned in Sephacryl S-100 column. (B) The active fractions were purified in trypsin-Sepharose column. The arrows indicate the beginning of elution with HCl 100 mM in trypsin-Sepharose and chitin columns. All fractions had the inhibitory activity against trypsin assayed. The inhibitory activities are showed as dotted lines.
Figure 3Binding of ApKTI in chitin column chromatography was used to demonstrate the affinity. The dotted line represents the binding of ApKTI in chitin column.
Figure 4Binding mode between ApKTI and trypsin. Kinetic studies were carried out using different concentration of inhibitor and substrate. Following the Michaelis–Menten parameters determination, the Dixon plot was obtained. The points where lines intersect the X-axis converge to a common point, while different 1/V were observed, determining a non-competitive inhibition mechanism between ApKTI and trypsin.
Figure 5Tri-N-acetylglucosamine in complex with ApKTI, where Arg64 and Arg66 located at the reactive site loop from ApKTI are involved in the complex stabilization (left). Adaptive Poisson–Boltzmann solver (APBS) electrostatic potential of ApKTI (potential ranges from −5 kT/e (red) to + 5 kT/e (blue)), highlighting the Arg64 and Arg66 residues and the hydrophobic pocket involved in GlcNAc attachment (right).
Structural statistics for the tridimensional theoretical models generated in this study for ApKTI, trypsin and chymotrypsin.
| Predicted Structures | Sequence Length | Fold Quality | Stereochemistry | Ramachandran | Bad Bonds | Bad Angles | ||
|---|---|---|---|---|---|---|---|---|
| Most Favored | Allowed | Outliers | ||||||
| ApKTI | 176 | −4.80 | −0.26 | 89.00 | 95.9 | 4.07 | 0 | 1.09 |
| Trypsin | 233 | −6.52 | −0.23 | 90.48 | 96.1 | 3.90 | 0 | 1.87 |
| Chymotrypsin | 238 | −6.47 | −0.24 | 91.50 | 97.9 | 2.12 | 0 | 1.70 |
The z-scores obtained for all structures here reported are in agreement with those with similar size, structurally determined by X-ray crystallography and deposited in the Protein Data Bank (PDB). The G-factors indicate that the overall average for the dihedral angles, along with the main-chain covalent forces for each structure are within the expected values for reliable structures (G-factors > −0.5). The structural validations were performed on ProSa-web [20], PROCHECK [21] and MolProbity [22].
Figure 6Tridimensional theoretical models for ApKTI, trypsin and chymotrypsin from P. interpunctella. β-strand scaffold showed two main cores formed by antiparallel β-strands, as well as α-helix and loop arrangements are observed in both enzymes. Predicted conformations for the (A) ApTI/trypsin and (C) ApTI/chymotrypsin complexes (yellow sticks represent the reactive site loop of ApTI). Atomic interactions involving Arg64 located at the reactive site loop from ApKTI are highlighted in the (B) ApKTI/trypsin and (D) ApTI/chymotrypsin complexes. Trypsin and chymotrypsin active sites are highlighted as white sticks.